These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33517002)

  • 101. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
    Liu B; Jin J; Zhang Z; Zuo L; Jiang M; Xie C
    Biochem Cell Biol; 2019 Aug; 97(4):397-405. PubMed ID: 30475643
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
    Yang J; Yang S; Zhou S; Lu D; Ji L; Li Z; Yu S; Meng X
    Eur J Med Chem; 2016 Oct; 122():488-496. PubMed ID: 27423028
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Synthesis, biological evaluation and virtual screening of some acridone derivatives as potential anticancer agents.
    Oyedele AS; Bogan DN; Okoro CO
    Bioorg Med Chem; 2020 May; 28(9):115426. PubMed ID: 32201193
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
    Halawa AH; Elgammal WE; Hassan SM; Hassan AH; Nassar HS; Ebrahim HY; Mehany ABM; El-Agrody AM
    Bioorg Chem; 2020 May; 98():103725. PubMed ID: 32199303
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors.
    Park SJ; Kim E; Yoo M; Lee JY; Park CH; Hwang JY; Ha JD
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4399-4404. PubMed ID: 28827110
    [TBL] [Abstract][Full Text] [Related]  

  • 107. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.
    Keller KE; Doctor ZM; Dwyer ZW; Lee YS
    Mol Cell; 2014 Mar; 53(5):700-9. PubMed ID: 24606918
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Small molecule activation of PKM2 in cancer cells induces serine auxotrophy.
    Kung C; Hixon J; Choe S; Marks K; Gross S; Murphy E; DeLaBarre B; Cianchetta G; Sethumadhavan S; Wang X; Yan S; Gao Y; Fang C; Wei W; Jiang F; Wang S; Qian K; Saunders J; Driggers E; Woo HK; Kunii K; Murray S; Yang H; Yen K; Liu W; Cantley LC; Vander Heiden MG; Su SM; Jin S; Salituro FG; Dang L
    Chem Biol; 2012 Sep; 19(9):1187-98. PubMed ID: 22999886
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Nitroimidazoles Part 10. Synthesis, crystal structure, molecular docking, and anticancer evaluation of 4-nitroimidazole derivatives combined with piperazine moiety.
    Al-Soud YA; Saber SOW; Shtaiwi A; Alsawakhneh SO; Alhelal KAS; Salman QFA; Abu-Qatouseh L; Khanfar MA; Al-Qawasmeh RA
    Z Naturforsch C J Biosci; 2023 Mar; 78(3-4):93-103. PubMed ID: 35589618
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation.
    Wan Y; Fang G; Chen H; Deng X; Tang Z
    Eur J Med Chem; 2021 Dec; 226():113837. PubMed ID: 34530384
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Computer-aided identification of a novel pyruvate kinase M2 activator compound.
    Li Y; Bao M; Yang C; Chen J; Zhou S; Sun R; Wu C; Li X; Bao J
    Cell Prolif; 2018 Dec; 51(6):e12509. PubMed ID: 30133040
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Design, synthesis and biological evaluation of rhein-piperazine-dithiocarbamate hybrids as potential anticancer agents.
    Wei MX; Zhou YX; Lin M; Zhang J; Sun X
    Eur J Med Chem; 2022 Nov; 241():114651. PubMed ID: 35963130
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Design, Synthesis and Biological Evaluation of Quinoline-8-Sulfonamides as Inhibitors of the Tumor Cell-Specific M2 Isoform of Pyruvate Kinase: Preliminary Study.
    Marciniec K; Rzepka Z; Chrobak E; Boryczka S; Latocha M; Wrześniok D; Beberok A
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985481
    [TBL] [Abstract][Full Text] [Related]  

  • 114. PKM2 Is Overexpressed in Glioma Tissues, and Its Inhibition Highly Increases Late Apoptosis in U87MG Cells With Low-density Specificity.
    Park JH; Lee JS; Oh Y; Lee JS; Park HE; Lee H; Park YS; Kyung SY; Kim HS; Yoon S
    In Vivo; 2022; 36(2):694-703. PubMed ID: 35241524
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Knowledge-driven design and optimization of potent symmetric anticancer molecules: A case study on PKM2 activators.
    Jaiswal E; Globisch C; Jain A
    Comput Biol Med; 2022 Dec; 151(Pt B):106313. PubMed ID: 36450217
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Parthenolide Derivatives as PKM2 Activators Showing Potential in Colorectal Cancer.
    Liu X; Wang C; Li S; Qu L; Yin F; Lu D; Luo H; Chen X; Luo Z; Cui N; Wang X; Kong L
    J Med Chem; 2021 Dec; 64(23):17304-17325. PubMed ID: 34847663
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.
    Boxer MB; Jiang JK; Vander Heiden MG; Shen M; Skoumbourdis AP; Southall N; Veith H; Leister W; Austin CP; Park HW; Inglese J; Cantley LC; Auld DS; Thomas CJ
    J Med Chem; 2010 Feb; 53(3):1048-55. PubMed ID: 20017496
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones.
    Chen C; Luo Y; Yin H; Zhong Q; Zheng S; Liu R; Zhao C; Wang G; He L
    Bioorg Med Chem; 2022 Apr; 60():116626. PubMed ID: 35255412
    [TBL] [Abstract][Full Text] [Related]  

  • 119. UNC1062, a new and potent Mer inhibitor.
    Liu J; Zhang W; Stashko MA; Deryckere D; Cummings CT; Hunter D; Yang C; Jayakody CN; Cheng N; Simpson C; Norris-Drouin J; Sather S; Kireev D; Janzen WP; Earp HS; Graham DK; Frye SV; Wang X
    Eur J Med Chem; 2013 Jul; 65():83-93. PubMed ID: 23693152
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents-In Vitro Evaluation against Breast Cancer Cells.
    Guillén-Mancina E; García-Lozano MDR; Burgos-Morón E; Mazzotta S; Martínez-Aguado P; Calderón-Montaño JM; Vega-Pérez JM; López-Lázaro M; Iglesias-Guerra F; Vega-Holm M
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.